|
|
||||||||
1 Department of Pharmaceutical Sciences, West Virginia University Health Sciences Center, Morgantown 26506; and 2 Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505
Interleukin (IL)-10 is an
anti-inflammatory cytokine that has great potential for use in the
treatment of inflammatory and immune illnesses. In this study, gene
transfer was used to induce IL-10 transgene expression in murine lungs
for treatment of endotoxin-induced lung inflammation. Gene transfer was
performed with a cytomegalovirus (CMV)-IL-10 plasmid with the aid of
the liposomal agents LipofectAMINE and
N-[1-(2,3-dioleoyl)propyl]-N,N,N-trimethylammonium
methylsulfate (DOTAP). Administration of the endotoxin caused a
marked increase in lung inflammation as indicated by increased tumor
necrosis factor (TNF)-
release and neutrophil count. Pretreatment of
the mice with IL-10 plasmid with and without LipofectAMINE had no inhibitory effect on lung inflammation and IL-10 transgene expression. LipofectAMINE by itself induced lung inflammation, an effect that was
not observed with DOTAP. IL-10 plasmid when codelivered with DOTAP
expressed biologically active IL-10 protein and caused a reduction in
endotoxin-induced inflammation. Transgene expression was observed as
early as 3 h after administration, peaked at 12 h, and
declined thereafter. We conclude that IL-10 gene transfer is a feasible
approach for the treatment of lung inflammation.
tumor necrosis factor-
; gene transfer; liposome
This article has been cited by other articles:
![]() |
S. Garantziotis, D. M. Brass, J. Savov, J. W. Hollingsworth, E. McElvania-TeKippe, K. Berman, J. K. L. Walker, and D. A. Schwartz Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled Endotoxin Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 662 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Deleuze, J. Lefort, M. F. Bureau, D. Scherman, and B. B. Vargaftig LPS-induced bronchial hyperreactivity: interference by mIL-10 differs according to site of delivery Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L98 - L105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ye, L. Wang, X. Zhang, V. Tantishaiyakul, and Y. Rojanasakul Inhibition of TNF-alpha gene expression and bioactivity by site-specific transcription factor-binding oligonucleotides Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L386 - L394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Knight, P. G. Holt, and P. D. Sly Lipopolysaccharide Inhibits the Late-Phase Response to Allergen by Altering Nitric Oxide Synthase Activity and Interleukin-10 Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 640 - 646. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |